Skip to content
OpenCapital
Get started

Turn Therapeutics Inc. TTRX Q4 2025 Annual earnings

Reported March 31, 2026 · Before market open

Diluted EPS-$0.09Miss by $0.04
EPS estimate-$0.05

Next report

Sep 2, 2026 (in 2 months)
EPS estimate-$0.02

Financials

Q4 2025

Income statement

See full
Operating income-$2.2M-567%

Balance sheet

See full
Cash & equivalents$5.1M+482%
Total debt$80.4K-33.6%
Total equity$4.7M+2,741%
Total assets$12.2M+494%

Cash flow

See full
Operating cash flow-$1.2M-173%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$116.01M—
Enterprise value$111.02M—

Returns & leverage

See full
Debt / equity0×—
Current ratio0.9×-0.7×

Versus estimates

Diluted EPS

Q1 2026-$0.03Miss by $0.01
Q4 2025-$0.09Miss by $0.04
Q3 2025-$0.07

Ask the moment Turn Therapeutics Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Turn Therapeutics Inc. report Q4 2025 earnings?
Turn Therapeutics Inc. (TTRX) reported Q4 2025 earnings on March 31, 2026 before market open.
What were Turn Therapeutics Inc.'s Q4 2025 revenue and EPS?
Turn Therapeutics Inc. reported diluted EPS of $-0.09 for Q4 2025.
Did Turn Therapeutics Inc. beat estimates in Q4 2025?
EPS missed the consensus estimate of $-0.05 by $0.04.
Where can I find Turn Therapeutics Inc.'s Q4 2025 SEC filings?
You can read the 8-K earnings release (0001213900-26-037470) and the 10-K periodic report (0001213900-26-037505) directly on SEC EDGAR. The filing index links above go to sec.gov.